2	O
.	O
2	O
.	O

Iris	B-Multi-tissue_structure
and	O
Ciliary	B-Multi-tissue_structure
Body	I-Multi-tissue_structure

Serotonin	O
is	O
present	O
in	O
mammalian	O
iris	B-Multi-tissue_structure
-	I-Multi-tissue_structure
ciliary	I-Multi-tissue_structure
body	I-Multi-tissue_structure
complex	I-Multi-tissue_structure
(	O
ICB	B-Multi-tissue_structure
)	O
at	O
higher	O
concentration	O
that	O
in	O
non	O
-	O
mammalian	O
species	O
[	O
5	O
,	O
45	O
,	O
73	O
,	O
129	O
,	O
137	O
]	O
.	O

Moreover	O
,	O
the	O
presence	O
of	O
serotonergic	O
nerves	B-Multi-tissue_structure
has	O
been	O
demonstrated	O
in	O
studies	O
conducted	O
on	O
the	O
ICB	B-Multi-tissue_structure
of	O
various	O
species	O
[	O
102	O
,	O
137	O
,	O
138	O
]	O
.	O

Experimental	O
evidence	O
and	O
radioligand	O
analyses	O
have	O
defined	O
the	O
presence	O
at	O
this	O
level	O
of	O
three	O
different	O
types	O
of	O
serotonin	O
receptors	O
[	O
10	O
,	O
28	O
,	O
85	O
,	O
136	O
,	O
137	O
]	O
,	O
i	O
.	O
e	O
.	O
5	O
-	O
HT1A	O
,	O
5	O
-	O
HT2A	O
/	O
2C	O
and	O
5	O
-	O
HT7	O
[	O
98	O
]	O
,	O
one	O
linked	O
to	O
a	O
stimulation	O
of	O
inositol	O
phosphates	O
(	O
5	O
-	O
HT2	O
subtype	O
)	O
,	O
while	O
the	O
others	O
two	O
are	O
linked	O
to	O
cAMP	O
activity	O
.	O

The	O
plausibility	O
of	O
the	O
existence	O
of	O
more	O
than	O
one	O
5	O
-	O
HT	O
receptor	O
type	O
in	O
the	O
ciliary	B-Multi-tissue_structure
body	I-Multi-tissue_structure
is	O
confirmed	O
by	O
intraocular	B-Immaterial_anatomical_entity
pressure	O
(	O
IOP	O
)	O
experiments	O
.	O

Topical	O
application	O
of	O
serotonin	O
has	O
been	O
reported	O
to	O
both	O
elevate	O
[	O
84	O
]	O
and	O
lower	O
[	O
88	O
]	O
IOP	O
in	O
rabbit	O
.	O

A	O
large	O
number	O
of	O
reports	O
have	O
shown	O
that	O
serotonin	O
agonists	O
and	O
antagonists	O
can	O
produce	O
increases	O
and	O
decreases	O
in	O
IOP	O
when	O
given	O
orally	B-Organism_subdivision
,	O
topically	O
to	O
the	O
eye	B-Organ
or	O
when	O
they	O
are	O
directly	O
injected	O
in	O
the	O
anterior	B-Multi-tissue_structure
chamber	I-Multi-tissue_structure
[	O
10	O
,	O
26	O
,	O
34	O
,	O
35	O
,	O
64	O
,	O
75	O
,	O
84	O
,	O
87	O
,	O
88	O
,	O
112	O
,	O
113	O
,	O
126	O
,	O
136	O
,	O
137	O
]	O
.	O

A	O
rationale	O
for	O
such	O
apparently	O
contradictory	O
results	O
may	O
be	O
due	O
to	O
the	O
different	O
sites	O
of	O
action	O
,	O
i	O
.	O
e	O
.	O
which	O
class	O
of	O
serotonin	O
receptor	O
is	O
activated	O
.	O

In	O
fact	O
,	O
in	O
rabbit	O
the	O
administration	O
of	O
5	O
-	O
methyl	O
-	O
urapidil	O
(	O
a	O
combined	O
5	O
-	O
HT1A	O
agonist	O
/	O
alpha1	O
adrenoreceptor	O
antagonist	O
)	O
and	O
8	O
-	O
OH	O
-	O
DPAT	O
(	O
8	O
-	O
hydroxydypropylaminotetralin	O
,	O
a	O
5HT1A	O
agonist	O
)	O
reduces	O
IOP	O
,	O
while	O
the	O
administration	O
of	O
5	O
-	O
CT	O
(	O
5	O
-	O
carboxamidotryptamine	O
,	O
a	O
5	O
-	O
HT1A	O
and	O
5	O
-	O
HT7	O
agonist	O
)	O
increases	O
IOP	O
[	O
36	O
,	O
84	O
,	O
99	O
]	O
.	O

Chidlow	O
,	O
Le	O
Corre	O
and	O
Osborne	O
[	O
28	O
]	O
have	O
recently	O
demonstrated	O
that	O
,	O
in	O
section	B-Multi-tissue_structure
taken	O
through	O
the	O
whole	O
eye	B-Organ
and	O
ciliary	B-Multi-tissue_structure
body	I-Multi-tissue_structure
,	O
prominent	O
5	O
-	O
HT1A	O
and	O
5	O
-	O
HT7	O
receptor	O
messenger	O
ribonucleic	O
acid	O
signals	O
were	O
obtained	O
.	O

These	O
signals	O
were	O
evident	O
in	O
both	O
the	O
pigmented	O
and	O
non	O
-	O
pigmented	O
epithelial	B-Cell
cell	I-Cell
layers	O
of	O
the	O
pars	B-Multi-tissue_structure
plicata	I-Multi-tissue_structure
region	O
of	O
the	O
ciliary	B-Multi-tissue_structure
processes	O
,	O
but	O
not	O
in	O
the	O
pars	B-Multi-tissue_structure
plana	I-Multi-tissue_structure
or	O
in	O
the	O
ciliary	B-Multi-tissue_structure
musculature	I-Multi-tissue_structure
.	O

5	O
-	O
HT1A	O
and	O
5	O
-	O
HT7	O
signals	O
were	O
apparent	O
in	O
the	O
posterior	O
processes	O
but	O
not	O
in	O
the	O
iris	B-Multi-tissue_structure
processes	O
.	O

The	O
presence	O
of	O
both	O
receptors	O
in	O
the	O
ciliary	B-Multi-tissue_structure
body	I-Multi-tissue_structure
would	O
certainly	O
provide	O
an	O
explanation	O
for	O
the	O
shallow	O
displacement	O
curves	O
observed	O
in	O
[	O
3H	O
]	O
5	O
-	O
HT	O
binding	O
studies	O
with	O
the	O
tissue	B-Tissue
[	O
110	O
]	O
,	O
since	O
this	O
ligand	O
can	O
be	O
used	O
to	O
label	O
both	O
receptors	O
.	O

Because	O
the	O
ciliary	B-Tissue
epithelium	I-Tissue
of	O
the	O
pars	B-Multi-tissue_structure
plicata	I-Multi-tissue_structure
is	O
responsible	O
for	O
the	O
secretion	O
of	O
aqueous	B-Organism_substance
humor	I-Organism_substance
,	O
an	O
obvious	O
function	O
for	O
these	O
two	O
receptors	O
would	O
be	O
an	O
involvement	O
in	O
the	O
control	O
of	O
aqueous	O
production	O
and	O
,	O
consequently	O
,	O
of	O
the	O
IOP	O
level	O
.	O

Further	O
,	O
the	O
almost	O
identical	O
distribution	O
of	O
the	O
5	O
-	O
HT1A	O
and	O
5	O
-	O
HT7	O
messengers	O
ribonucleic	O
acid	O
indicate	O
that	O
the	O
receptors	O
may	O
be	O
co	O
-	O
localized	O
in	O
epithelial	B-Cell
cells	I-Cell
.	O

The	O
presence	O
of	O
two	O
serotonin	O
receptors	O
with	O
opposing	O
effects	O
on	O
cAMP	O
in	O
the	O
same	O
cell	B-Cell
layer	O
prompts	O
the	O
suggestion	O
that	O
they	O
could	O
act	O
antagonistically	O
.	O

The	O
agonism	O
of	O
5	O
-	O
HT1A	O
receptors	O
,	O
negatively	O
coupled	O
to	O
cAMP	O
,	O
reduces	O
IOP	O
by	O
decreasing	O
the	O
production	O
of	O
aqueous	B-Organism_substance
humor	I-Organism_substance
,	O
like	O
beta	O
-	O
receptor	O
antagonists	O
which	O
,	O
diminishing	O
the	O
content	O
of	O
cAMP	O
at	O
the	O
postjunctional	O
site	O
,	O
lowers	O
the	O
aqueous	B-Organism_substance
humor	I-Organism_substance
secretion	O
with	O
a	O
consequent	O
decrease	O
in	O
IOP	O
[	O
98	O
]	O
.	O

On	O
the	O
contrary	O
,	O
the	O
administration	O
of	O
5	O
-	O
CT	O
induces	O
a	O
rise	O
in	O
IOP	O
,	O
which	O
is	O
partly	O
or	O
entirely	O
caused	O
by	O
an	O
increase	O
in	O
aqueous	B-Organism_substance
humor	I-Organism_substance
secretion	O
mediated	O
by	O
5	O
-	O
HT7	O
receptors	O
[	O
84	O
]	O
.	O

The	O
other	O
type	O
of	O
serotonin	O
receptor	O
present	O
in	O
the	O
ICB	B-Multi-tissue_structure
is	O
a	O
5	O
-	O
HT2	O
type	O
.	O

Serotonin	O
stimulates	O
the	O
accumulation	O
of	O
inositol	O
phosphates	O
in	O
the	O
ICB	B-Multi-tissue_structure
and	O
this	O
effect	O
is	O
partially	O
counteracted	O
by	O
the	O
5	O
-	O
HT2	O
antagonists	O
ketanserin	O
,	O
methysergide	O
and	O
mianserin	O
[	O
98	O
]	O
.	O

Studies	O
with	O
ketanserin	O
have	O
demonstrated	O
that	O
,	O
when	O
orally	B-Organism_subdivision
or	O
topically	O
applied	O
,	O
it	O
lowers	O
IOP	O
in	O
animals	O
,	O
healthy	O
volunteers	O
and	O
in	O
glaucomatous	B-Pathological_formation
patients	O
[	O
26	O
,	O
34	O
,	O
37	O
,	O
64	O
,	O
75	O
,	O
88	O
,	O
113	O
,	O
126	O
]	O
.	O

It	O
has	O
been	O
emphasized	O
that	O
ketanserin	O
also	O
possesses	O
an	O
affinity	O
for	O
alpha1	O
-	O
adrenoreceptors	O
[	O
27	O
,	O
36	O
,	O
139	O
]	O
,	O
and	O
for	O
this	O
reason	O
the	O
effects	O
of	O
ketanserin	O
on	O
IOP	O
may	O
not	O
be	O
entirely	O
caused	O
by	O
its	O
action	O
on	O
5	O
-	O
HT2	O
receptors	O
.	O

However	O
,	O
data	O
from	O
human	O
studies	O
conducted	O
after	O
oral	B-Organism_subdivision
or	O
topical	O
administration	O
of	O
ketanserin	O
,	O
in	O
which	O
were	O
determined	O
the	O
variations	O
of	O
IOP	O
,	O
total	O
outflow	O
facility	O
and	O
pupil	B-Multi-tissue_structure
diameter	O
,	O
demonstrated	O
that	O
the	O
alpha1	O
-	O
adrenoreceptor	O
blocking	O
effect	O
exerted	O
by	O
ketanserin	O
should	O
represent	O
a	O
further	O
aspect	O
of	O
its	O
mechanism	O
of	O
action	O
,	O
probably	O
due	O
to	O
a	O
functional	O
sharing	O
of	O
these	O
receptors	O
[	O
64	O
,	O
87	O
]	O
.	O

Lastly	O
,	O
already	O
in	O
1992	O
Martin	O
and	O
co	O
-	O
workers	O
showed	O
the	O
occurrence	O
of	O
a	O
significant	O
correlation	O
between	O
the	O
content	O
of	O
serotonin	O
in	O
the	O
aqueous	B-Organism_substance
humor	I-Organism_substance
and	O
IOP	O
in	O
the	O
human	O
eye	B-Organ
[	O
85	O
]	O
.	O

In	O
1981	O
,	O
Moro	O
and	O
his	O
collaborators	O
found	O
that	O
intravitreal	O
injection	O
of	O
5	O
,	O
6	O
-	O
dihydroxytryptamine	O
,	O
a	O
serotonergic	O
neurotoxin	O
,	O
causes	O
miosis	O
[	O
91	O
]	O
.	O

The	O
identification	O
of	O
5	O
-	O
HT7	O
,	O
but	O
not	O
of	O
5	O
-	O
HT1	O
receptors	O
in	O
the	O
rabbit	O
iris	B-Multi-tissue_structure
,	O
suggests	O
that	O
this	O
population	O
of	O
serotonergic	O
receptors	O
is	O
involved	O
in	O
the	O
relaxation	O
of	O
the	O
sphincter	B-Tissue
of	O
the	O
pupil	B-Multi-tissue_structure
.	O

In	O
fact	O
,	O
one	O
of	O
the	O
function	O
correlate	O
to	O
5	O
-	O
HT7	O
receptor	O
activation	O
includes	O
smooth	B-Tissue
muscle	I-Tissue
relaxation	O
observed	O
in	O
a	O
variety	O
of	O
isolated	O
tissue	B-Tissue
preparations	O
,	O
in	O
which	O
elevation	O
of	O
cAMP	O
concentration	O
was	O
also	O
detected	O
[	O
3	O
,	O
44	O
]	O
.	O

Further	O
evidence	O
for	O
the	O
mediation	O
of	O
the	O
relaxant	O
response	O
via	O
the	O
5	O
-	O
HT7	O
receptor	O
is	O
provided	O
by	O
the	O
localization	O
of	O
messenger	O
ribonucleic	O
acid	O
transcripts	O
encoding	O
the	O
5	O
-	O
HT7	O
receptor	O
in	O
many	O
blood	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
[	O
67	O
]	O
.	O

This	O
hypothesized	O
mechanism	O
of	O
action	O
is	O
also	O
supported	O
by	O
the	O
fact	O
that	O
various	O
other	O
receptor	O
types	O
,	O
also	O
positively	O
coupled	O
to	O
cAMP	O
,	O
in	O
the	O
iris	B-Multi-tissue_structure
cause	O
relaxation	O
of	O
the	O
sphincter	B-Tissue
muscle	I-Tissue
[	O
1	O
,	O
28	O
]	O
.	O

